US7247442B1ExpiredUtilityA1
Antibodies to HHPEN62 polypeptide
Est. expiryMay 12, 2018(expired)· nominal 20-yr term from priority
C07K 14/47
83
PatentIndex Score
7
Cited by
47
References
24
Claims
Abstract
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
Claims
exact text as granted — not AI-modified1. An isolated antibody or fragment thereof that specifically binds to a polypeptide selected from the group consisting of:
(a) a polypeptide whose amino acid sequence consists of amino acid residues 1 to 508 of SEQ ID NO:139;
(b) a polypeptide whose amino acid sequence consists of a portion of SEQ ID NO:139, wherein said portion is at least 30 contiguous amino acid residues of SEQ ID NO:139; and
(c) a polypeptide whose amino acid sequence consists of a portion of SEQ ID NO:139, wherein said portion is at least 50 contiguous amino acid residues of SEQ ID NO:139.
2. The antibody or fragment thereof of claim 1 that specifically binds polypeptide (a).
3. The antibody or fragment thereof of claim 1 that specifically binds polypeptide (b).
4. The antibody or fragment thereof of claim 1 that specifically binds polypeptide (c).
5. The antibody or fragment thereof of claim 3 that specifically binds a polypeptide whose amino acid sequence consists of amino acid residues 1 to 508 of SEQ ID NO:139.
6. The antibody or fragment thereof of claim 1 , which is a polyclonal antibody.
7. The antibody or fragment thereof of claim 1 , which is a monoclonal antibody.
8. The antibody or fragment thereof of claim 1 , which is selected from the group consisting of:
(a) a chimeric antibody;
(b) a human antibody;
(c) a humanized antibody;
(d) a single chain antibody; and
(e) a Fab fragment.
9. The antibody or fragment thereof of claim 1 , which is labeled.
10. The antibody or fragment thereof of claim 1 wherein said polypeptide bound by said antibody or fragment thereof is glycosylated.
11. The antibody or fragment thereof of claim 1 wherein said antibody or fragment thereof specifically binds to said polypeptide in a Western blot.
12. The antibody or fragment thereof of claim 1 wherein said antibody or fragment thereof specifically binds to said polypeptide in an ELISA.
13. An isolated cell that produces the antibody or fragment thereof of claim 1 .
14. A hybridoma that produces the antibody or fragment thereof of claim 1 .
15. The antibody or fragment thereof of claim 2 , which is a polyclonal antibody.
16. The antibody or fragment thereof of claim 2 , which is a monoclonal antibody.
17. The antibody or fragment thereof of claim 2 which is selected from the group consisting of:
(a) a chimeric antibody;
(b) a human antibody;
(c) a humanized antibody;
(d) a single chain antibody; and
(e) a Fab fragment.
18. The antibody or fragment thereof of claim 2 , which is labeled.
19. The antibody or fragment thereof of claim 2 wherein said polypeptide bound by said antibody or fragment thereof is glycosylated.
20. The antibody or fragment thereof of claim 2 wherein said antibody or fragment thereof specifically binds to said polypeptide in a Western blot.
21. The antibody or fragment thereof of claim 2 wherein said antibody or fragment thereof specifically binds to said polypeptide in an ELISA.
22. An isolated cell that produces the antibody or fragment thereof of claim 2 .
23. A hybridoma that produces the antibody or fragment thereof of claim 2 .
24. A method of detecting a polypeptide comprising amino acid residues 1 to 508 of SEQ ID NO:139 in a biological sample comprising:
(a) contacting the biological sample with the antibody or fragment thereof of claim 1 ;
(b) allowing a complex to form between said polypeptide comprising amino acid residues 1 to 508 of SEQ ID NO:139 and said antibody of claim 1 ; and,
(c) detecting said complex.Join the waitlist — get patent alerts
Track US7247442B1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.